Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

348047

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the treatment of hidradenitis suppurativa cost the NHS in England in (a) 2012, (b) 2013 and (c) 2014.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	745
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 746 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348048

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	746
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 745 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225202

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to ensure the vaccination of eligible people who have not previously accessed the shingles vaccine.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226309
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>We are committed to delivering the Joint Committee on Vaccination and Immunisation’s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.</p><p> </p><p> </p><p> </p><p>This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 226311 question first answered 09/03/2015 16:06:24 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225203

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the shingles vaccination will be included as an indicator in the Public Health Outcomes Framework along with other recommended vaccination programmes.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226310
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>There will be a review of the Public Health Outcomes Framework later in 2015. Any proposal to include shingles vaccination as an indicator will be considered as part of the review process.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 16:04:54 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225204

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the Government plans to make the shingles vaccine available to everyone who requests it in the 70-79 age group.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226311
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>We are committed to delivering the Joint Committee on Vaccination and Immunisation’s (JCVI) recommendation on shingles immunisation. The vaccine is being offered routinely to those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, the vaccine was offered to all those aged 70 and 79 years old. In 2014/15 the vaccine was offered to all those aged 70, 78 and 79 years old and in 2015/16, the vaccine will be offered to those aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>General practitioners may also continue to offer immunisation to all those who have become eligible as 70 year olds from 1 September 2013 but have not yet been immunised.</p><p> </p><p> </p><p> </p><p>This progressive programme will ensure that all those JCVI has recommended be vaccinated will be offered the vaccine.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 226309 question first answered 09/03/2015 16:06:24 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

225205

registered interest
date	04/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the current shingles vaccination schedule is for 70 to 79 year olds; and if he will make a statement.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	226312
answer	answer is ministerial correction date of answer 09/03/2015 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that shingles vaccine should be offered to all those aged 70 – 79 years. The vaccine is being routinely offered to all those aged 70 years and to all those aged 71 to 79 years through a progressive catch-up.</p><p> </p><p> </p><p> </p><p>In the first year of the programme, 2013/14, shingles vaccination was offered to patients aged 70 and 79 years old. For 2014/15, we are offering vaccination to patients aged 70, 78 and 79 years old and, for 2015/16, we will offer the vaccine to patients aged 70 and 78 years old.</p><p> </p><p> </p><p> </p><p>We are committed to delivering the JCVI’s recommendation in full. Eligibility criteria for immunisation in each year of the programme are informed by the volumes of vaccine that have been contracted and scheduled for delivery in that particular year.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/03/2015 15:54:49 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

172549

registered interest
date	07/01/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dermatology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to curb excessive disparities in the cost of dispensing (a) dermatology and (b) non-dermatology preferred unlicensed dermatological preparations; and what steps he is taking to ensure that all pharmacies in England obtain a whole-of-market quote from manufacturers of such preparations, as is the case in Scotland.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	220033
answer	answer is ministerial correction date of answer 12/01/2015 answer text <p>The Drug Tariff sets out what National Health Service dispensing contractors will be paid for the products supplied as part of providing pharmaceutical services and the fees for providing those services in primary care.</p><p> </p><p> </p><p> </p><p>The current arrangements for paying for unlicensed medicines were introduced in 2011. These arrangements, unlike the ones for Scotland, do not require pharmacy contractors to obtain a whole-of-market quote from manufacturers. However, the Drug Tariff sets the price that the NHS pays to dispensing contractors for dispensing many of the most popular specials. Setting a reimbursement price, applied to all contractors, stops disparity of payment for these products and encourages dispensing contractors to obtain best value for the NHS, while also ensuring patients receive the medicines they need, when they need them. Due to the number of unlicensed medicines that can potentially be prescribed, it is not possible to list a reimbursement price for all available specials.</p><p> </p><p> </p><p> </p><p>Where the reimbursement price of a product has not been set, dispensing contractors are paid according to how the product is sourced. Where a dispensing contractor buys the product from a specials manufacturer or an importing company, they must claim the invoice price of the pack size used to dispense the product minus any discounts or rebates received.</p><p> </p><p> </p><p> </p><p>NHS England is responsible for commissioning pharmaceutical services in primary care and it is for NHS England to consider whether dispensing contractors have acted appropriately, including excessive claims for payment made by contractors. In addition, the General Pharmaceutical Council is responsible for regulating the pharmacy professions should there be any concerns of professional misconduct.</p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 12/01/2015 15:05:25 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	103 label Biography information for Sir Paul Beresford

91465

registered interest
date	10/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sunbeds
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the All-Party Parliamentary Group on Skin report on sunbed regulation, published in May 2014; when he plans to announce his Department's response to that report; and whether his Department is preparing secondary legislation to implement the conditions of that report.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	209022
answer	answer is ministerial correction date of answer 13/10/2014 answer text <p>The Department is carefully assessing the All-Party Parliamentary Group on Skin’s recommendations and we will provide our response by the end of October.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 13/10/2014 14:15:45 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

90723

registered interest
date	04/09/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Dental Council
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 2 September 2014, Official Report, on the General Dental Council, if (a) his Department and (b) the Professional Standards Authority For Health and Social Care will publish its review of the business case for the increase in years charged by the General Dental Council; and if similar reviews will be published of the Care Quality Commission increase in fees to dental professionals.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	208258
answer	answer is ministerial correction date of answer 09/09/2014 answer text <p> </p><p>The business case referred to in the answer given on 2 August 2014 is the General Dental Council’s (GDC) consultation document setting out the GDC’s rationale for the proposed fee rise. The consultation closed on 4 September 2014 and the document is available at:</p><p> </p><p> </p><p> </p><p>www.gdc-uk.org/GDCcalendar/Consultations/Pages/Consultation-on-the-Annual-Retention-Fee-(ARF)-Level-for-2015.aspx</p><p> </p><p> </p><p> </p><p>The GDC is an independent body and therefore neither the Department nor The Professional Standards Authority for Health and Social Care as a formal role in reviewing the GDC’s case. However, in my role as Parliamentary Under Secretary for Health, on 3 September 2014 I met with the GDC where this issue was discussed.</p><p> </p><p><strong> </strong></p><p> </p><p>Each year the Care Quality Commission (CQC) consults on its proposed fee structure for the following year. The CQC intends to publish a consultation on its proposed fee structure for 2015-16 and draft impact assessment in the next month. The final impact assessment will be published in 2015. These documents will be available on the CQC’s website. Following consultation, the CQC will present its proposals to my Rt. Hon. Friend the Secretary of State for Health.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 09/09/2014 14:48:44 answering member 3932 label Biography information for Dr Dan Poulter attachment 1 file name PQ208258 - Hansard Extract.docx title Hansard Extract
tabling member	103 label Biography information for Sir Paul Beresford

79367

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Dental Council
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on top-level pay at the General Dental Council.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	207017
answer	answer is ministerial correction date of answer 01/09/2014 answer text <p>The General Dental Council is an independent body, directly accountable to Parliament. It is therefore for the General Dental Council to determine its top-level pay. However the Department expects all regulators to show restraint and to set salaries which are appropriate.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 01/09/2014 13:57:02 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	103 label Biography information for Sir Paul Beresford